Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × Positron Emission Tomography Computed Tomography × 90 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neuroendocrine Tumors 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Neuroendocrine 1 Cancer Patients Referred to do PET/CT Study 1

Interventions

Biopsy 5 Specimen Handling 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 belinostat 2 X-Rays 2 Whole-Body Irradiation 2 10-propargyl-10-deazaaminopterin 2 tazemetostat 1 talimogene laherparepvec 1 sodium-iodide symporter 1 ruxolitinib 1 romidepsin 1 fludarabine 1 enasidenib 1 duvelisib 1 cemiplimab 1 brincidofovir 1 Triamcinolone 1 Tacrolimus 1 Spinal Puncture 1 Solutions 1 Rituximab 1 Photons 1 Pharmacokinetics 1 Pharmacogenomic Variants 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mycophenolic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡